BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 21994208)

  • 1. Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomy.
    Iwai A; Koga F; Fujii Y; Masuda H; Saito K; Numao N; Sakura M; Kawakami S; Kihara K
    Jpn J Clin Oncol; 2011 Dec; 41(12):1373-9. PubMed ID: 21994208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
    Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
    BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer.
    Eswara JR; Efstathiou JA; Heney NM; Paly J; Kaufman DS; McDougal WS; McGovern F; Shipley WU
    J Urol; 2012 Feb; 187(2):463-8. PubMed ID: 22177159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer.
    Yoshida S; Koga F; Kobayashi S; Ishii C; Tanaka H; Tanaka H; Komai Y; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e21-7. PubMed ID: 22414281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
    Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
    Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
    Koga F; Kihara K; Fujii Y; Yoshida S; Saito K; Masuda H; Kageyama Y; Kawakami S
    BJU Int; 2009 Jul; 104(2):189-94. PubMed ID: 19154452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
    Gakis G; Efstathiou J; Lerner SP; Cookson MS; Keegan KA; Guru KA; Shipley WU; Heidenreich A; Schoenberg MP; Sagaloswky AI; Soloway MS; Stenzl A;
    Eur Urol; 2013 Jan; 63(1):45-57. PubMed ID: 22917985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan.
    Takada N; Abe T; Shinohara N; Sazawa A; Maruyama S; Shinno Y; Sato S; Mitsuhashi K; Sato T; Sugishita K; Kamota S; Yamashita T; Ishizaki J; Hioka T; Mouri G; Ono T; Miyajima N; Sakuta T; Mochizuki T; Aoyagi T; Katano H; Akino T; Hirakawa K; Minami K; Kumagai A; Seki T; Togashi M; Nonomura K
    BJU Int; 2012 Dec; 110(11 Pt B):E756-64. PubMed ID: 23107013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of postoperative complications in open versus robotic cystectomy.
    Ng CK; Kauffman EC; Lee MM; Otto BJ; Portnoff A; Ehrlich JR; Schwartz MJ; Wang GJ; Scherr DS
    Eur Urol; 2010 Feb; 57(2):274-81. PubMed ID: 19560255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical analysis of complications after robotic-assisted radical cystectomy with identification of preoperative and operative risk factors.
    Kauffman EC; Ng CK; Lee MM; Otto BJ; Portnoff A; Wang GJ; Scherr DS
    BJU Int; 2010 Feb; 105(4):520-7. PubMed ID: 19735257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications and mortality after radical cystectomy for bladder transitional cell cancer.
    Novara G; De Marco V; Aragona M; Boscolo-Berto R; Cavalleri S; Artibani W; Ficarra V
    J Urol; 2009 Sep; 182(3):914-21. PubMed ID: 19616246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus.
    Maffezzini M; Campodonico F; Canepa G; Gerbi G; Parodi D
    Surg Oncol; 2008 Jul; 17(1):41-8. PubMed ID: 17962014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?
    Donat SM; Siegrist T; Cronin A; Savage C; Milowsky MI; Herr HW
    J Urol; 2010 Jun; 183(6):2171-7. PubMed ID: 20399461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach.
    Inoue M; Koga F; Yoshida S; Tamura T; Fujii Y; Ito E; Kihara K
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):303-11. PubMed ID: 25304790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
    Lin CC; Hsu CH; Cheng JC; Huang CY; Tsai YC; Hsu FM; Huang KH; Cheng AL; Pu YS
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):442-8. PubMed ID: 19307067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy.
    Yuh BE; Nazmy M; Ruel NH; Jankowski JT; Menchaca AR; Torrey RR; Linehan JA; Lau CS; Chan KG; Wilson TG
    Eur Urol; 2012 Nov; 62(5):806-13. PubMed ID: 22705382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of early postoperative morbidity after robot-assisted and open radical cystectomy: results of a prospective observational study.
    Musch M; Janowski M; Steves A; Roggenbuck U; Boergers A; Davoudi Y; Loewen H; Groeben H; Kroepfl D
    BJU Int; 2014 Mar; 113(3):458-67. PubMed ID: 24053793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of early complications after radical cystectomy: results of a collaborative care pathway.
    Chang SS; Cookson MS; Baumgartner RG; Wells N; Smith JA
    J Urol; 2002 May; 167(5):2012-6. PubMed ID: 11956429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.